March 26, 2025 20:19 ET | Source: Mesoblast Limited NEW YORK, March 26, 2025 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO;…
December 18, 2024 19:08 ET | Source: Mesoblast Limited RYONCIL (remestemcel-L) is the first MSC product approved by FDA for…